Table 1

General characteristics of research participants (n=63)

VariablesPatients, n (%)
Age (months)*16 (6–165)
Gender
 Male34 (54)
 Female29 (46)
Body weight (kg)*8.7 (6.3–38)
History of growth failure
 Yes48 (76.2)
 No15 (23.8)
Diagnosis
 Biliary atresia51 (80.9)
 Caroli disease2 (3.2)
 Alagille syndrome3 (4.8)
 Choledochal cyst3 (4.8)
 Autoimmune hepatitis1 (1.6)
 Budd-Chiari syndrome1 (1.6)
 Neonatal hepatitis1 (1.6)
 Extrahepatic portal vein thrombosis1 (1.6)
History of surgery
 Yes9 (14.3)
 No54 (85.7)
Donor
 Maternal33 (52.4)
 Paternal26 (41.3)
 Others (aunt/uncle)4 (6.3)
 Donor age (years)*32 (21–55)
ABO incompatibility
 Yes2 (3.2)
 No61 (96.8)
Donor macrosteatosis
 None (≤5%)47 (74.6)
 Very mild (>5% to 15%)12 (19.0)
 Mild (>15% to 30%)2 (3.17)
 Moderate (>30% to 60%)2 (3.17)
 Severe (>60%)0
Billiary anastomosis
 141 (65.1)
 222 (34.9)
Early relaparotomy15 (23.8)
PELD score*17 (6–36)
Surgery duration (min)* (n=60)720 (480–1440)
Blood loss (mL/kg body weight)* (n=58)81 (17–581)
Warm ischemic time (min)† (n=59)61±27
Cold ischemic time (min)* (n=59)62 (19–273)
  • *Data are presented with median (range).

  • †Data are presented with mean±SD.

  • PELD, pediatric end-stage liver disease; SD, standard deviation.